Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Spannagl

Showing results (1-10 of 119) with videos related to

Pageof 12
Sort By:
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|August 20, 2008
[Daily thrombocyte count in low molecular weight heparin treatment]Michael Spannagl
Innere Medizin (Heidelberg, Germany)|August 30, 2024
[Hemophilia: is a revolution in treatment options taking place?]Michael Spannagl
Clinical Chemistry and Laboratory Medicine|March 3, 2017
New perspectives on existing data in comparative measurements: a simple extension of the regression analysisJürgen Durner, Michael Spannagl
Thrombosis and Haemostasis|March 22, 2014
Activators, therapeutics and immunity-related aspects of thrombosisBernd Engelmann, Michael Spannagl
Thrombosis and Haemostasis|September 4, 2008
Deep venous thrombosis of the upper extremity: is thrombophilia a relevant clinical issue?Ulrich Hoffmann, Michael Spannagl
EJIFCC|September 30, 2016
Platelet Function Testing-Guided Antiplatelet TherapyEkaterina Lenk, Michael Spannagl
Deutsches Arzteblatt International|April 20, 2018
Insufficient DataThomas Schachtner, Michael Spannagl
Wiener Medizinische Wochenschrift (1946)|March 16, 2011
Monitoring of direct anticoagulantsSusanne Lison, Michael Spannagl
Anesthesia and Analgesia|April 26, 2002
Caveat against the use of activated recombinant factor VII for intractable bleeding in cardiac surgeryWulf Dietrich, Michael Spannagl
Anesthesia and Analgesia|October 26, 2011
Review article: unexpected bleeding in the operating room: the role of acquired von Willebrand diseaseSusanne Lison, Wulf Dietrich, Michael Spannagl
Pageof 12

Showing results (1-10 of 119) with videos related to

Sort By:
Pageof 12
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|August 20, 2008
[Daily thrombocyte count in low molecular weight heparin treatment]Michael Spannagl
Innere Medizin (Heidelberg, Germany)|August 30, 2024
[Hemophilia: is a revolution in treatment options taking place?]Michael Spannagl
Clinical Chemistry and Laboratory Medicine|March 3, 2017
New perspectives on existing data in comparative measurements: a simple extension of the regression analysisJürgen Durner, Michael Spannagl
Thrombosis and Haemostasis|March 22, 2014
Activators, therapeutics and immunity-related aspects of thrombosisBernd Engelmann, Michael Spannagl
Thrombosis and Haemostasis|September 4, 2008
Deep venous thrombosis of the upper extremity: is thrombophilia a relevant clinical issue?Ulrich Hoffmann, Michael Spannagl
EJIFCC|September 30, 2016
Platelet Function Testing-Guided Antiplatelet TherapyEkaterina Lenk, Michael Spannagl
Deutsches Arzteblatt International|April 20, 2018
Insufficient DataThomas Schachtner, Michael Spannagl
Wiener Medizinische Wochenschrift (1946)|March 16, 2011
Monitoring of direct anticoagulantsSusanne Lison, Michael Spannagl
Anesthesia and Analgesia|April 26, 2002
Caveat against the use of activated recombinant factor VII for intractable bleeding in cardiac surgeryWulf Dietrich, Michael Spannagl
Anesthesia and Analgesia|October 26, 2011
Review article: unexpected bleeding in the operating room: the role of acquired von Willebrand diseaseSusanne Lison, Wulf Dietrich, Michael Spannagl
Pageof 12